As we age, our cells acquire cancer-causing mutations, but mutations alone are rarely enough to start a tumor. An ...
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...
A new era in the treatment of deadly pancreatic cancer was heralded by scientists this week, thanks to science by the ...
By Deena Beasley June 3 (Reuters) - Cathy Smithwick, now 67, has lived with breast cancer, and then ovarian cancer, for more ...
Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly ...
Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new targe…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
A new once-daily pill almost doubled the survival time for patients battling an aggressive and advanced form of pancreatic ...
New research shows a medication called daraxonrasib is helping people with advanced pancreatic cancer live longer.
The new breast cancer screening guidelines are creating mixed signals on when to start screening. Medical News Today spoke to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results